Organ-Specific Cancers: Diagnosis to Therapy Webinar Series

Challenges in Management of Bladder and Prostate Cancer in 2021: What Happens When the Standard of Care Is Not Enough?

April 22, 2021
5:00 pm to 6:30 pm

 

Accreditation

The Columbia University Vagelos College of Physicians and Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Columbia University Vagelos College of Physicians and Surgeons designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

  • Lisa A. Kachnic, MD, FASTRO
    Chu H. Chang Professor
    Chair, Department of Radiation Oncology, Columbia University Vagelos College of Physicians and Surgeons

Faculty

  • Christopher B. Anderson, MD, MPH
    Assistant Professor of Urology, Columbia University Vagelos College of Physicians and Surgeons
  • Guarionex Joel Decastro, MD, MPH
    Assistant Professor of Urology, Columbia University Vagelos College of Physicians and Surgeons
  • James M. McKiernan, MD
    John K. Lattimer Professor of Urology; Director, Urologic Oncology
    Chair, Department of Urology, Columbia University Vagelos College of Physicians and Surgeons
  • Catherine S. Spina, MD, PhD
    Assistant Professor of Radiation Oncology, Columbia University Vagelos College of Physicians and Surgeons
  • Mark N. Stein, MD
    Associate Professor of Medical Oncology, Columbia University Vagelos College of Physicians and Surgeons

Program Description & Objectives

This symposium will focus on updating practicioners in recent developments in the management of high risk localized prostate cancer, BCG unresponsive nonmusclei invasive bladder cancer as well as the multidisciplinary management of muscle invasive bladder cancer. These updates will include descriptions of the epidemiology of these entities as well as recently published data describing innovative ways of managing these three clinical disease states. A particular focus will be placed on ongoing clinical trials available at Columbia University’s Herbert Irving Cancer Center. Target audience: practicing urologists, medical oncologists, radiation oncologists, nurse practitioners, and trainees interested in prostate and bladder cancer care.

Agenda

  • 5:00 PM: Welcome
    • James M. McKiernan, MD
  • 5:05 PM: High Risk Localized Prostate Cancer: Updates in Multidisciplinary Care
    • Christopher B. Anderson, MD, MPH
    • Catherine S. Spina, MD, PhD
  • 5:25 PM: BCG Unresponsive High Risk Non-Muscle Invasive Bladder Cancer: An Expanding Menus of Options
    • Guarionex Joel Decastro, MD, MPH
  • 5:45 PM: Muscle Invasive Bladder Cancer: It’s Not Just Cystectomy Anymore
    • Mark N. Stein, MD
  • 6:05 PM: Q&A
  • 6:30 PM: Adjourn

Registration

Register via Zoom